AbCellera Biologics Inc. ABCL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$143.96M+14.2% | -$146.41M+10.1% | -$171.68M+2.3% | -$165.67M-8.1% | -$167.87M-14.3% | ||
| $19.9M+45.2% | $18.39M+47.7% | $15.31M+7.5% | $14.81M+9.4% | $13.71M+4.3% | ||
| $53.02M-18.4% | $55.79M-17.4% | $58.11M-15.5% | $61.38M-9.1% | $64.96M-1.8% | ||
| -$153.26M-95.5% | -$131.3M-20.9% | -$104.55M+13.0% | -$80.84M+11.5% | -$78.4M— | ||
| $35.97M-44.6% | $42.77M-45.4% | $48.56M-37.1% | $58.15M-26.4% | $64.89M-24.6% | ||
| $54.73M-45.0% | $87.75M-27.7% | $48.32M-21.3% | $15.53M-65.4% | $99.43M+339% | ||
| —— | —— | —— | —— | $15.91M+16.6% | ||
| —— | —— | -$43.48M+5.0% | -$55.88M-77.8% | $35.69M+151% | ||
| -$189.23M-32.1% | -$174.07M+6.9% | -$153.11M+22.4% | -$138.99M+18.4% | -$143.29M-12.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.